A Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation

Clinical trial NCT03995901 · TERMINATED

Trial details

NCT number: NCT03995901
Sponsor: Talaris Therapeutics Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Transplanted Organ Rejection

Start date: 2019-10-25
Primary completion: 2023-02-16
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.